Scientists encourage immediate action from policymakers and the health community as Antimicrobial Resistance (AMR) – the ability of a microorganism to resist the effects of a drug, making it less effective – continues to threaten global health.
In 2019, approximately 4.95 million people died from illnesses in which bacterial AMR played a part, of which 1.27 million deaths were the direct result of AMR. Furthermore, infections didn't respond to two classes of first-line antibiotics in over 70% of those 1.27 million deaths. These fatalities are already more than deaths caused by HIV/AIDS or Malaria, and the WHO, with several other public health agencies, are projecting ~10 million deaths per year by 2050.
Out of the several measures that scientists recommend immediately, they think that the most critical approach is the use of antibiotics only after confirmed diagnosis and an antibiotic susceptibility profile of the causative agent is performed. They also highlight the need to advocate for significantly expanded laboratory and diagnostics capacity in many low- and middle-income countries where data on AMR is scarce.
As a leader in infectious disease testing, Acutis continues to introduce evolving technology and science to provide our customers with better, more actionable data and ever-more accurate results. Our Reveal™ lines of tests offer the exacting science and precise detection of key pathogens to prevent misdiagnoses and the potentially inappropriate use of antibiotics.
When treating a patient, choose Acutis Reveal™ for the greatest degree of certainty.
